PMID: 11921057Mar 29, 2002Paper

Nuclear factor-kappaB as a molecular target for migraine therapy

Annals of Neurology
U ReuterM A Moskowitz

Abstract

Nitric oxide (NO) generated from inducible NO synthase (iNOS) participates in immune and inflammatory responses in many tissues. The NO donor glyceryl trinitrate (GTN) provokes delayed migraine attacks when infused into migraineurs and also causes iNOS expression and delayed inflammation within rodent dura mater. Sodium nitroprusside, an NO donor as well, also increases iNOS expression. Because inflammation and iNOS are potential therapeutic targets, we examined transcriptional regulation of iNOS following GTN infusion and the consequences of its inhibition within dura mater. We show that intravenous GTN increases NO production within macrophages. L-N(6)-(1-iminoethyl)lysine, a selective iNOS inhibitor, attenuates the NO signal, emphasizing the importance of enzymatic activity to delayed NO production. iNOS expression is preceded by significant nuclear factor kappa B (NF-kappaB) activity, as reflected by a reduction in the inhibitory protein-kappa-Balpha (IkappaBalpha) and activation of NF-kappaB after GTN infusion. IkappaBalpha degradation, NF-kappaB activation, and iNOS expression were attenuated by parthenolide (3mg/kg), the active constituent of feverfew, an anti-inflammatory drug used for migraine treatment. These findings...Continue Reading

References

Jan 1, 1991·Journal of Neurology·E J Mylecharane
Sep 1, 1986·The Journal of Pharmacy and Pharmacology·W A GroenewegenS Heptinstall
Feb 1, 1966·Archives of Environmental Health·D C Trainor, R C Jones
Mar 30, 1994·Biochemical and Biophysical Research Communications·I M AdcockP J Barnes
Mar 1, 1993·British Journal of Pharmacology·J AssreuyS Moncada
Jun 9, 1995·The Journal of Biological Chemistry·H B PengJ K Liao
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K BrownU Siebenlist
Jan 1, 1996·Critical Reviews in Neurobiology·H Y YunT M Dawson
Feb 8, 1997·Lancet·L H LassenJ Olesen
May 19, 1997·Biochemical and Biophysical Research Communications·P C KuoR A Schroeder
Jun 1, 1997·Journal of Natural Products·J T WeberK K Parker
Nov 25, 1998·Biochemical and Biophysical Research Communications·M B MarreroR C Venema
Apr 27, 1999·The Journal of Pharmacy and Pharmacology·H TournierP Mordujovich de Buschiazzo
Jan 7, 2000·Journal of Ethnopharmacology·N K Jain, S K Kulkarni
May 9, 2000·Biochemical and Biophysical Research Communications·B HinzA Pahl
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L ConnellyA J Hobbs
Aug 14, 2001·The Journal of Biological Chemistry·A J García-PiñeresI Merfort
Sep 5, 2001·Cephalalgia : an International Journal of Headache·M G JonesA Parsons
Nov 10, 2001·Brain : a Journal of Neurology·U ReuterM A Moskowitz
Nov 1, 1996·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·C J De WeerdtH Hendriks

❮ Previous
Next ❯

Citations

Mar 7, 2003·European Journal of Pharmacology·Cristina TassorelliGiuseppe Nappi
Feb 3, 2007·American Journal of Respiratory Cell and Molecular Biology·Aicha SaadaneMelvin Berger
Oct 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Nicoletta Galeotti, Carla Ghelardini
Oct 31, 2006·Pharmacology & Therapeutics·Saurabh GuptaAntoinette MaassenVanDenBrink
Mar 9, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Amynah A PradhanSimon Akerman
Feb 14, 2003·Current Neurology and Neuroscience Reports·Margarita Sánchez del Río, Uwe Reuter
Jan 30, 2004·Annual Review of Medicine·Avi Ashkenazi, Stephen D Silberstein
Feb 4, 2005·Cephalalgia : an International Journal of Headache·N OffenhauserU Reuter
Apr 28, 2005·Expert Review of Neurotherapeutics·Thomas M BuchananSheena Aurora
Feb 8, 2008·Cephalalgia : an International Journal of Headache·A RahmannM Ashina
Sep 13, 2011·Headache·Hayrunnisa Bolay, Alan Rapoport
Aug 7, 2012·Molecular and Cellular Biochemistry·Flavia M GonçalvesJose E Tanus-Santos
Apr 5, 2013·The Journal of Obstetrics and Gynaecology Research·Zhihong AiYincheng Teng
Aug 15, 2014·Expert Review of Neurotherapeutics·Patrizia RipaSimona Sacco
Jun 15, 2017·Frontiers in Pharmacology·Théophile Godfraind
Feb 19, 2020·Journal of Neuroinflammation·Giovanna CasiliEmanuela Esposito
Dec 1, 2017·Translational and Clinical Pharmacology·Wonsuk ShinKyoung Soo Lim
Sep 12, 2006·Cephalalgia : an International Journal of Headache·A CannasM G Marrosu
Jul 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Elio Agostoni, Angelo Aliprandi
Jun 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ellen Niederberger, Gerd Geisslinger
Sep 9, 2009·Cephalalgia : an International Journal of Headache·H DoganayH Bolay
Mar 1, 2011·Headache·Frederick R Taylor
Oct 30, 2015·Cephalalgia : an International Journal of Headache·Gábor Nagy-GróczÁrpád Párdutz
Mar 1, 2016·Current Treatment Options in Neurology·Rashmi B HalkerTodd J Schwedt
Apr 20, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Till SprengerC Tassorelli
Jul 11, 2019·Headache·Zachariah Bertels, Amynah Amir Ali Pradhan
Jan 20, 2004·Cephalalgia : an International Journal of Headache·G SancesG Nappi
Sep 29, 2006·The European Journal of Neuroscience·A BergerotP J Goadsby
May 12, 2006·Cephalalgia : an International Journal of Headache·U ArulmaniP R Saxena
Feb 26, 2004·Current Pain and Headache Reports·Nabih M Ramadan
Sep 22, 2007·Headache·Marcela Romero-Reyes, Steven Graff-Radford
Dec 10, 2003·Expert Opinion on Emerging Drugs·Christian Waeber
Nov 1, 2003·Expert Review of Neurotherapeutics·Jonathan P Gladstone, David W Dodick
Oct 27, 2010·Cephalalgia : an International Journal of Headache·Hans Olav HøivikMartin W Lunnon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.